MAP1LC3A and proximal spinal muscular atrophy: We suggest that the positive modifier effect of in vivo calpeptin treatment on SMA mice survival and motor phenotype could be the result of SMN protein and LC3 autophagosome protein regulation in SMA MNs and could offer a viable therapeutic approach.